News
Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Pfizer and BioNTech have announced ... monovalent – containing or encoding the spike protein of only the Original SARS-CoV-2 virus – COVID-19 vaccine or receipt of the most recent booster ...
The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results